Madison, WI, United States of America

Carl J Malizio


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Carl J Malizio

Introduction

Carl J Malizio is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of pharmaceuticals, particularly in targeting therapeutic molecules to motor neurons. With a total of 3 patents to his name, Malizio's work has the potential to impact the treatment of neurological disorders.

Latest Patents

Malizio's latest patents include a method of targeting pharmaceuticals to motor neurons. This innovative method involves synthesizing a prodrug that comprises a therapeutic molecule covalently bound to a polymeric delivery vehicle. Additionally, the prodrug is conjugated to a botulinum neurotoxin heavy chain, enhancing its effectiveness. Another significant patent is for a chimeric toxin, which combines a botulinal neurotoxin heavy chain with a non-clostridial toxin chain. This chimeric toxin is designed for pharmacological treatment of neurological disorders, showcasing Malizio's commitment to advancing medical science.

Career Highlights

Carl J Malizio is associated with the Wisconsin Alumni Research Foundation, where he continues to innovate and develop new therapeutic methods. His work is characterized by a strong focus on improving the delivery of pharmaceuticals to specific target areas in the nervous system.

Collaborations

Malizio has collaborated with notable colleagues, including Eric Arthur Johnson and Michael C Goodnough. These partnerships have likely contributed to the success and development of his innovative ideas.

Conclusion

Carl J Malizio's contributions to the field of pharmaceuticals through his patents and innovative methods highlight his role as a significant inventor. His work not only advances medical treatments but also exemplifies the importance of targeted therapies in addressing complex neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…